SEC Form 4 · accession 0001022079-17-000007
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine T. Doherty
Officer — SVP, Clin. Franchise Solutions
Period of report
Jan 30, 2017
Accepted (ET)
Feb 1, 2017 · 8:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 30, 2017 | M | 42,586 | $52.165 | A | 119,321 | D | |
| Common StockF1 | Jan 30, 2017 | S | 31,100 | $90.419 | D | 88,221 | D | |
| Common StockF2 | Jan 30, 2017 | S | 11,486 | $91.612 | D | 76,735 | D | |
| Common Stock | Jan 30, 2017 | M | 37,414 | $56.12 | A | 114,149 | D | |
| Common StockF3 | Jan 30, 2017 | S | 37,414 | $90.396 | D | 76,735 | D | |
| Common StockF4 | holding | — | — | — | 294 | I | SDCP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F5 | $52.165 | Jan 30, 2017 | M | 42,586 | D | — | Feb 13, 2024 | Common Stock | 42,586 | 21,294 | D |
| Stock Options (Right to Buy)F5 | $56.12 | Jan 30, 2017 | M | 37,414 | D | — | Feb 25, 2023 | Common Stock | 37,414 | 6,595 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $90.14 to $91.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $91.14 to $91.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $90.15 to $90.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4These underlying shares were acquired on a periodic basis by the trustee of the Company's Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
- F5The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.